Unlocking early detection: the role of DNA methylation biomarkers in colorectal cancer tumorigenesis – a systematic review

Background: DNA methylation is an epigenetic mechanism that holds promise for improving disease detection, particularly in the early stages of neoplastic transformation. Although colonoscopy is currently the most effective method for detecting colorectal cancer (CRC) due to its high sensitivity, patient compliance is often hindered by its invasive nature, high cost, and inconvenient preparation process. This systematic review aims to systematically identify DNA methylation-based biomarkers used in early-stage CRC detection and to systematically compile evidence on the roles of DNA methylation-based biomarkers in CRC tumorigenesis. Methods: Data were collected via electronic searches for relevant citations from 2018 to 2023 in PubMed, Scopus, and Cochrane Library, using relevant and specific keywords for the search strategy. The selection of relevant articles is associated with the inclusion and exclusion criteria. The quality of the articles was assessed using the Crowe Critical Appraisal Tool (CCAT). Results: From an initial pool of 121 articles, 14 articles were selected based on the inclusion criteria and PRISMA guidelines. This systematic review successfully identified relevant DNA methylation-based biomarkers that have potential in early-stage CRC detection which are SDC2, KCNQ5, C9orf50, CLIP4, a combination of SEPT9 and SDC2, and a combination of GALNT9 and UPF3A. These biomarkers have been shown to have high accuracy and can be identified in a noninvasive approach such as stool and blood, demonstrating their potential as an effective tool for early CRC detection. Additionally, DNA methylation biomarkers were shown to be involved in key processes of CRC tumorigenesis, including cell proliferation, migration, transformation, metastasis, and angiogenesis. Conclusion: This systematic review highlights the promising role of DNA methylation-based biomarkers in the early detection of CRC, offering a non-invasive approach and highly accurate alternative to traditional methods.

Publication Details

Journal
The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
Published
2024-12-27
Primary Topic
Magnetic confinement fusion research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unlocking early detection: the role of DNA methylation biomarkers in colorectal cancer tumorigenesis – a systematic review

The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
Magnetic confinement fusion research
article

Unlocking early detection: the role of DNA methylation biomarkers in colorectal cancer tumorigenesis – a systematic review

article en

Abstract

Background: DNA methylation is an epigenetic mechanism that holds promise for improving disease detection, particularly in the early stages of neoplastic transformation. Although colonoscopy is currently the most effective method for detecting colorectal cancer (CRC) due to its high sensitivity, patient compliance is often hindered by its invasive nature, high cost, and inconvenient preparation process. This systematic review aims to systematically identify DNA methylation-based biomarkers used in early-stage CRC detection and to systematically compile evidence on the roles of DNA methylation-based biomarkers in CRC tumorigenesis. Methods: Data were collected via electronic searches for relevant citations from 2018 to 2023 in PubMed, Scopus, and Cochrane Library, using relevant and specific keywords for the search strategy. The selection of relevant articles is associated with the inclusion and exclusion criteria. The quality of the articles was assessed using the Crowe Critical Appraisal Tool (CCAT). Results: From an initial pool of 121 articles, 14 articles were selected based on the inclusion criteria and PRISMA guidelines. This systematic review successfully identified relevant DNA methylation-based biomarkers that have potential in early-stage CRC detection which are SDC2, KCNQ5, C9orf50, CLIP4, a combination of SEPT9 and SDC2, and a combination of GALNT9 and UPF3A. These biomarkers have been shown to have high accuracy and can be identified in a noninvasive approach such as stool and blood, demonstrating their potential as an effective tool for early CRC detection. Additionally, DNA methylation biomarkers were shown to be involved in key processes of CRC tumorigenesis, including cell proliferation, migration, transformation, metastasis, and angiogenesis. Conclusion: This systematic review highlights the promising role of DNA methylation-based biomarkers in the early detection of CRC, offering a non-invasive approach and highly accurate alternative to traditional methods.

The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
International Islamic University Malaysia
Reduced inequalities
Openalex Percentile: Top 60%
Magnetic confinement fusion research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.